Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Mazdutide Plus LNG-IUS for Fertility-Sparing Treatment of AEH or Early Endometrial Cancer	Body Weight, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, atypical endometrial hyperplasia, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, nutritional disorder, obesity disorder, overnutrition, uterine disorder	Not yet recruiting	Phase 2	2026-08-24		NCT07781150

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Innovent Biologics, Inc.	10
Tongji Hospital	276

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Shanghai Tenth People's Hospital	Shanghai	China	13
The First Affiliated Hospital of Zhengzhou University	Zhengzhou	China	103
The Second Hospital of Jilin University	Changchun	China	11
Tianjin Medical University General Hospital	Tianjin	China	28
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology	Wuhan	China	20
Zhejiang Cancer Hospital	Hangzhou	China	84